FISH & RICHARDSON
Fish & Richardson was all over the map last year, with appearances in 222 new patent cases in federal courts across the United States, plus a major U.S. Supreme Court win and successful litigation at the International Trade Commission (ITC). The firm also scored two key victories in cases involving the Hatch-Waxman Act, the federal law governing the procedure for bringing generic drugs to market.
This premium content is reserved for National Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now